Latest Lead News

Page 43 of 462
Bannerman Energy reports steady progress on its Etango Uranium Project with key construction milestones met and a strong cash position, while uranium market fundamentals continue to strengthen. The company targets a positive Final Investment Decision within the next 6 to 12 months.
Maxwell Dee
Maxwell Dee
29 Jan 2026
Australian Critical Minerals has raised $3 million through a heavily oversubscribed placement to fund maiden drilling at its promising Flint Gold-Silver Project in Peru.
Maxwell Dee
Maxwell Dee
29 Jan 2026
Broken Hill Mines has delivered a standout December quarter with record mining rates at Rasp Mine, strong exploration results, and a robust financial position, setting the stage for accelerated growth in 2026.
Maxwell Dee
Maxwell Dee
29 Jan 2026
Genesis Minerals delivered record gold production and a robust cash build in December 2025, while accelerating development at its Tower Hill project ahead of schedule.
Maxwell Dee
Maxwell Dee
29 Jan 2026
Critical Resources Limited has secured a $1.75 million placement at market price, reinforcing investor confidence as it advances lithium, gold-antimony, and solid-state battery initiatives.
Maxwell Dee
Maxwell Dee
29 Jan 2026
Biotron Limited has completed the acquisition of Sedarex Limited alongside a $2.5 million capital raising, while its lead Hepatitis B drug candidate BIT-HBV001 shows promising preclinical results outperforming current treatments.
Ada Torres
Ada Torres
29 Jan 2026
Racura Oncology reported a transformative quarter with key scientific discoveries, expanded clinical programs, and a robust cash position of $20.94 million, setting the stage for pivotal cancer trials in 2026.
Ada Torres
Ada Torres
29 Jan 2026
Genesis Minerals has restructured its executive team, appointing Raleigh Finlayson as Executive Chair and promoting Matthew Nixon to CEO, positioning the company for a significant growth phase.
Maxwell Dee
Maxwell Dee
29 Jan 2026
CurveBeam AI reported steady progress in Q2 FY26 with five new device purchase orders, a $4 million milestone payment pending receipt, and key regulatory submissions underway in the US and China.
Ada Torres
Ada Torres
29 Jan 2026
Arovella Therapeutics has secured a crucial regulatory nod from the U.S. FDA, allowing its lead CAR-iNKT cell therapy, ALA-101, to enter first-in-human clinical trials targeting blood cancers.
Ada Torres
Ada Torres
29 Jan 2026
dorsaVi reports strong US commercial growth with over 100 new physical therapy sites and a 50% rise in cash receipts, alongside a strategic leadership change and breakthrough neuromorphic technology acquisition.
Sophie Babbage
Sophie Babbage
29 Jan 2026
Silver Mines Limited has reported its best-ever drilling results at the Bowdens Silver Project in NSW while navigating a complex regulatory redetermination process. Exploration advances continue across its Australian and US projects, supported by a strong cash position.
Maxwell Dee
Maxwell Dee
29 Jan 2026